Financial results - BIO MAX PHARMA COMPANY S.R.L.

0.00
Financial Summary - Bio Max Pharma Company S.r.l.
Unique identification code: 43031604
Registration number: J05/1629/2020
Nace: 4646
Sales - Ron
1.126
Net Profit - Ron
-4.726
Employee
1
Open Account
The most important financial indicators for the company Bio Max Pharma Company S.r.l. - Unique Identification Number 43031604: sales in 2023 was 1.126 euro, registering a net profit of -4.726 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Bio Max Pharma Company S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - - 97.873 57.700 6.305 1.126
Total Income - EUR - - - - - - 97.875 57.701 6.309 1.126
Total Expenses - EUR - - - - - - 72.761 66.770 14.411 5.843
Gross Profit/Loss - EUR - - - - - - 25.114 -9.069 -8.102 -4.717
Net Profit/Loss - EUR - - - - - - 24.135 -9.506 -8.162 -4.726
Employees - - - - - - 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -82.1%, from 6.305 euro in the year 2022, to 1.126 euro in 2023.
See Company Data

Check the financial reports for the company - Bio Max Pharma Company S.r.l.

Rating financiar

Rating financiar -
Bio Max Pharma Company S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bio Max Pharma Company S.r.l. - CUI 43031604

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 1.011 817 - - - - - -
Current Assets - - - - - - 49.412 47.604 42.646 37.290
Inventories - - - - - - 10.633 25.553 24.708 23.892
Receivables - - - - - - 2.152 3.268 1.769 4.368
Cash - - - - - - 36.626 18.783 16.170 9.030
Shareholders Funds - - - - - - 24.342 14.296 6.179 1.434
Social Capital - - - - - - 207 202 203 202
Debts - - - - - - 25.886 34.318 36.468 35.856
Income in Advance - - - - - - 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 37.290 euro in 2023 which includes Inventories of 23.892 euro, Receivables of 4.368 euro and cash availability of 9.030 euro.
The company's Equity was valued at 1.434 euro, while total Liabilities amounted to 35.856 euro. Equity decreased by -4.726 euro, from 6.179 euro in 2022, to 1.434 in 2023.
Monitors the Company

Activate a subscription with unlimited access and get contact details for any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Recurring - monthly payment

Pay

25,21 EUR / month
NELIMITAT

Reports that can be accessed based on the subscription:

  • ✔ Financial Rating
  • ✔ Payment Limits
  • ✔ Outstanding Debts
  • ✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
See Subscriptions

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.